Print Page  Close Window
Investor Overview
Company Overview
PDI is a leading health care commercialization company providing superior insight-driven, integrated multi-channel message delivery to established and emerging health care companies. The company is dedicated to enhancing engagement with health care practitioners and optimizing commercial investments for its clients by providing strategic flexibility, full product commercialization services, innovative multi-channel promotional solutions, and sales and marketing expertise.... More >>
Recent News
DateTitle 
10/31/14PDI, Inc. Announces Date & Time Change for Third Quarter Financial Results Conference Call
PARSIPPANY, N.J., Oct. 31, 2014 /PRNewswire/ -- PDI, Inc. (Nasdaq:PDII) today announced that it has adjusted the date and time it will release its third quarter 2014 financial results and operational highlights. The company will now release its results on Monday, November 3, 2014 and will host a conference call on Monday, November 3 at 8:00 a.m. Eastern Time to discuss the results.   Access information: Date: Monday, November 3, 2014 Time... 
Printer Friendly Version
10/30/14John Climaco Resigns from PDI's Board of Directors
PARSIPPANY, N.J., Oct. 30, 2014 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII), a leading healthcare commercialization company, announced today that John Climaco has resigned from its board of directors effective October 29, 2014. He served in this role since October 2013. Mr. Climaco most recently co-founded Axial Biotech, Inc., a venture-backed molecular diagnostics company specializing in spine disorders, in 2003, and served as the president, chief executive officer and board member until 201... 
Printer Friendly Version
10/30/14PDI, Inc. Confirms Receipt of Unsolicited Acquisition Proposal from Digirad Corporation
PDI's Board of Directors Indicates Company is Not For Sale PARSIPPANY, N.J., Oct. 30, 2014 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII), a leading healthcare commercialization company, has responded to the letter dated October 29, 2014 from Digirad Corporation regarding Digirad's willingness to offer to acquire PDI by indicating that PDI is not for sale and does not view Digirad's letter to be a meaningful offer to acquire PDI.    The full text of the letter which reinforces the view of PDI ... 
Printer Friendly Version
10/27/14PDI, Inc. to Hold Third Quarter Financial Results Conference Call on Tuesday, November 4, 2014
PARSIPPANY, N.J., Oct. 27, 2014 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that it will release its third quarter 2014 financial results and operational highlights on Monday, November 3, 2014 after the market close and host a conference call on Tuesday, November 4 at 8:30 am Eastern time to discuss the results.     Access information: Date: Tuesday, November 4, 2014 Time: 8:30 am ... 
Printer Friendly Version
More >>

Primary IR Contact
Asher Dewhurst
Westwick Partners
Phone: 443.213.0503
Email: Asher.Dewhurst@westwicke.com

Stock Quote
PDII (Common Stock)
ExchangeNASDAQ GM (US Dollar)
Price$1.90
Change (%) Stock is Up 0.27 (16.56%)
Volume135,700
Data as of 10/30/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Webcasts
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.